Related Experiment Videos

Recent data on mitral valve prolapse and magnesium deficit

C D Zeana1

  • 1Medical Clinic, Emergency Hospital Bucharest, Romania.

Magnesium Research
|December 1, 1988
PubMed

Insights

Idiopathic mitral valve prolapse (IMVP) is linked to magnesium deficit, often stemming from lifestyle factors. Magnesium therapy can effectively manage symptoms and potentially reverse the condition.

Area of Science:

  • Cardiology
  • Biochemistry
  • Genetics

Background:

  • Idiopathic mitral valve prolapse (IMVP) is a common condition with varied symptoms.
  • IMVP symptoms can overlap with latent tetany due to magnesium deficit (LTMD).
  • Magnesium deficit is a key factor in IMVP development.

Purpose of the Study:

  • To explore the relationship between magnesium deficit and IMVP.
  • To identify factors contributing to magnesium deficit and IMVP.
  • To evaluate the efficacy of magnesium therapy for IMVP.

Main Methods:

  • Clinical investigation including echocardiogram and electrocardiogram.
  • Assessment of plasma and erythrocyte magnesium, calcium levels, and urinary calcium.
  • Analysis of contributing factors like diet, stress, hormones, and genetics (HLA Bw35).

Main Results:

  • Magnesium deficit is a primary cause of IMVP, often linked to latent tetany.
  • Factors like stress, diet, hormonal influences, and HLA Bw35 antigen contribute to magnesium depletion.
  • Magnesium therapy effectively controls latent tetany and leads to morphologic recovery in IMVP.

Conclusions:

  • Magnesium deficit is a significant underlying cause of idiopathic mitral valve prolapse.
  • Consistent, long-term magnesium therapy is crucial for managing IMVP and latent tetany.
  • Administering magnesium can prevent the progression of IMVP in individuals with latent tetany.

Related Concept Videos